A1C reductions averaged 1.8% by week 12 in the diabetic subgroup, representing meaningful metabolic improvement beyond weight loss alone
This hormone has multiple mechanisms of action, all potentially useful in the treatment of diabetes as well as weight loss
GLP-1 has very significant glucagon suppressive effects at normal plasma glucose levels and at elevated plasma glucose levels
After a two-year consistent treatment regimen, patients on Wegovy are predicted to shed 15.2% of their total weight
MeAgain keeps the shot history, side-effect logging (the 18 most common, plus unlimited custom symptoms), and custom notes together so the week is easier to inspect after the fact
"There does seem to be a biological signal emerging to say that maybe these drugs have an impact" on risks for various types and stages of cancer, Dr